Cardioprotective	cardioprotective	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
salvianolic	salvianolic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
A	a	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
designed	designed	O	O	O	O
to	to	O	O	O	O
evaluate	evaluate	O	O	O	O
the	the	O	O	O	O
cardioprotective	cardioprotective	O	O	O	O
potential	potential	O	O	O	O
of	of	O	O	O	O
salvianolic	salvianolic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
A	a	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Hemodynamic	hemodynamic	O	O	O	O
parameters	parameters	O	O	O	O
and	and	O	O	O	O
lead	lead	O	O	OTHERS	I
II	ii	O	O	O	O
electrocardiograph	electrocardiograph	O	O	O	O
were	were	O	O	O	O
monitored	monitored	O	O	O	O
and	and	O	O	O	O
recorded	recorded	O	O	O	O
continuously	continuously	O	O	O	O
.	.	O	O	O	O

Cardiac	cardiac	O	O	O	O
marker	marker	O	O	O	O
enzymes	enzymes	O	O	O	O
and	and	O	O	O	O
antioxidative	antioxidative	O	O	O	O
parameters	parameters	O	O	O	O
in	in	O	O	O	O
serum	serum	O	O	O	O
and	and	O	O	O	O
heart	heart	O	O	O	O
tissues	tissues	O	O	O	O
were	were	O	O	O	O
measured	measured	O	O	O	O
.	.	O	O	O	O

Assay	assay	O	O	O	O
for	for	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
respiratory	respiratory	O	O	O	O
function	function	O	O	O	O
and	and	O	O	O	O
histopathological	histopathological	O	O	O	O
examination	examination	O	O	O	O
of	of	O	O	O	O
heart	heart	O	O	O	O
tissues	tissues	O	O	O	O
were	were	O	O	O	O
performed	performed	O	O	O	O
.	.	O	O	O	O

Isoproterenol-treated	isoproterenol-treated	O	O	O	O
rats	rats	O	O	O	O
showed	showed	O	O	O	O
significant	significant	O	O	O	O
increases	increases	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
lactate	lactate	CHEMICALS	O	OTHERS	I
dehydrogenase	dehydrogenase	O	O	O	O
,	,	O	O	O	O
aspartate	aspartate	CHEMICALS	O	OTHERS	I
transaminase	transaminase	O	O	O	O
,	,	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
kinase	kinase	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
malondialdehyde	malondialdehyde	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
significant	significant	O	O	O	O
decreases	decreases	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
activities	activities	O	O	O	O
of	of	O	O	O	O
superoxide	superoxide	CHEMICALS	O	OTHERS	I
dismutase	dismutase	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
catalase	catalase	O	O	O	O
and	and	O	O	O	O
glutathione	glutathione	CHEMICALS	O	OTHERS	I
peroxidase	peroxidase	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
serum	serum	O	O	O	O
and	and	O	O	O	O
heart	heart	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
rats	rats	O	O	O	O
also	also	O	O	O	O
showed	showed	O	O	O	O
declines	declines	O	O	O	O
in	in	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
systolic	systolic	O	O	O	O
pressure	pressure	O	O	O	O
,	,	O	O	O	O
maximum	maximum	O	O	O	O
and	and	O	O	O	O
minimum	minimum	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
developed	developed	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
pressure	pressure	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
elevation	elevation	O	O	O	O
of	of	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
pressure	pressure	O	O	O	O
and	and	O	O	O	O
ST-segment	st-segment	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
,	,	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
respiratory	respiratory	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
characterized	characterized	O	O	O	O
by	by	O	O	O	O
decreased	decreased	O	O	O	O
respiratory	respiratory	O	O	O	O
control	control	O	O	O	O
ratio	ratio	O	O	O	O
and	and	O	O	O	O
ADP/O	adp/o	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
isoproterenol-treated	isoproterenol-treated	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Administration	administration	O	O	O	O
of	of	O	O	O	O
salvianolic	salvianolic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
A	a	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
a	a	O	O	O	O
period	period	O	O	O	O
of	of	O	O	O	O
8	8	O	O	O	O
days	days	O	O	O	O
significantly	significantly	O	O	O	O
attenuated	attenuated	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
and	and	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
and	and	O	O	O	O
improved	improved	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
respiratory	respiratory	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
protective	protective	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
salvianolic	salvianolic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
A	a	CHEMICALS	O	OTHERS	I
against	against	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
was	was	O	O	O	O
further	further	O	O	O	O
confirmed	confirmed	O	O	O	O
by	by	O	O	O	O
histopathological	histopathological	O	O	O	O
examination	examination	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
our	our	O	O	O	O
study	study	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
salvianolic	salvianolic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
A	a	CHEMICALS	O	OTHERS	I
possessing	possessing	O	O	O	O
antioxidant	antioxidant	O	O	O	O
activity	activity	O	O	O	O
has	has	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
protective	protective	O	O	O	O
effect	effect	O	O	O	O
against	against	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

